CUSIP: 89620X506
Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
941,232
-
Share change
-
+535,984
-
Total reported value
-
$19,033,000
-
Price per share
-
$20.23
-
Number of holders
-
13
-
Value change
-
+$11,333,757
-
Number of buys
-
10
-
Number of sells
-
6
Institutional Holders of TRILLIUM THERAPEUTICS INC - COM NEW as of Q1 2015
As of 31 Mar 2015,
TRILLIUM THERAPEUTICS INC - COM NEW was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
941,232 shares.
The largest 10 holders included
Opaleye Management Inc., DEERFIELD MANAGEMENT CO, venBio Select Advisor LLC, SPHERA FUNDS MANAGEMENT LTD., Private Capital Advisors, Inc., Spark Investment Management LLC, BOGLE INVESTMENT MANAGEMENT L P /DE/, Monashee Investment Management LLC, A.R.T. Advisors, LLC, and DEUTSCHE BANK AG\.
This page lists
13
institutional shareholders reporting positions in this security
for the Q1 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.